Peptide record

TPDB64277

Phage clone 1.2 Phage clone 1.3 Blood-Brain Barrier Cell-penetrating Peptides standard
12 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB64277
Phage clone 1.2 Phage clone 1.3
Blood-Brain Barrier Cell-penetrating Peptides
Delivery and barrier-penetrating peptides
B3Pred BBPpredict Peptipedia CPPsite3.0
standard
No
A 12-aa standard-residue multi-activity (Blood-Brain Barrier and Cell-penetrating Peptides) peptide sequence curated from B3Pred, BBPpredict, Peptipedia, and other sources, with an available 3D structural model.
Sequence
VAARTGEIYVPW
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C64H96N16O17
NDCQHLKMFS
AV
1361.56
6.90
1
1
7
-0
0.38
0.300
97.50
Mammalian: 100 hour Yeast: >20 hour E.coli: >10 hour
6990
5.13
2
Residue Composition
number
2
A
1
R
0
N
0
D
0
C
1
E
0
Q
1
G
0
H
1
I
0
L
0
K
0
M
0
F
1
P
0
S
1
T
1
W
1
Y
2
V
Amino Acid Distribution
A: 2 R: 1 N: 0 D: 0 C: 0 E: 1 Q: 0 G: 1 H: 0 I: 1 L: 0 K: 0 M: 0 F: 0 P: 1 S: 0 T: 1 W: 1 Y: 1 V: 2
Chemical Descriptors
12 reviewed residue count
C64H96N16O17 sequence-only estimate (linear, free termini)
1361.56 sequence-only estimate (linear, free termini)
6.90 sequence-only estimate (linear, free termini)
-0 sequence-only estimate (linear, free termini)
0.38 sequence-only estimate (linear, free termini)
0.300 sequence-only estimate (linear, free termini)
Free Activity
L Activity
Linear Activity
Linear Activity
Free Activity
Cationic Activity
ValAlaAlaArgThrGlyGluIleTyrValProTrp Activity
N[C@@]([H])(C(C)C)C(=O)N[C@@]([H])(C)C(=O)N[C@@]([H])(C)C(=O)N[C@@]([H])(CCCNC(=N)N)C(=O)N[C@@]([H])([C@]([H])(O)C)C(=O)NCC(=O)N[C@@]([H])(CCC(=O)O)C(=O)N[C@@]([H])([C@]([H])(CC)C)C(=O)N[C@@]([H])(Cc1ccc(O)cc1)C(=O)N[C@@]([H])(C(C)C)C(=O)N1[C@@]([H])(CCC1)C(=O)N[C@@]([H])(CC(=CN2)C1=C2C=CC=C1)C(=O)O NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)O Activity
Evidence Records 2 records
Evidence 1 Activity

Activity

Blood-Brain Barrier
1.5 x 10e-6 cm/s

Target

SH-SY5Y cells

Assay & Model

UHPLC-MS/MS
The phage display adverses the BBB with the peptide.
Stability/half life

Source & Reference

NA
B3Pdb

Other

Chemically synthesized
Peptides bound specifically to primary endothelial cells and could traverse the BBB.
Transcytosis
Combined with phage display
Evidence 2 Activity

Activity

Cell-penetrating Peptides

Target

Primary Rat Endothelial Cells And SH-SY5Y Neuroblastoma Cell Line.

Source & Reference

CPPsite3.0
CPPsite3

Other

Source Activity Label Source Definition
Cell-penetrating Peptides
CPPsite3.0 experimentally validated cell-penetrating peptide annotation.
Natural residues Linear L
Synthetic
Biotin-labeled
Able to internalize into primary endothelial cells (with higher efficiency than GLHTSATNLYLH) while internalization of N–C reversed sequence peptide into primary endothelial cells was negligible.
Energy dependent pathway
In vitro
CCCCCCCCCC
Additional Detail Fields 1 fields
CCCCCCCCCC